Barbiturate reversal of amino acid antagonism produced by convulsant agents.
D000613:Aminobutyrates / Q000494:pharmacology*; D000818:Animals; D001463:Barbiturates / Q000494:pharmacology; D001640:Bicuculline / Q000037:antagonists & inhibitors* / Q000378:metabolism; D001665:Binding Sites; D001933:Brain Stem / Q000187:drug effects*; D018756:GABA Antagonists; D005725:Ganglia, Autonomic / Q000187:drug effects*; D005998:Glycine / Q000037:antagonists & inhibitors / Q000494:pharmacology; D007546:Isoquinolines / Q000037:antagonists & inhibitors*; D009474:Neurons / Q000187:drug effects; D010424:Pentobarbital / Q000378:metabolism / Q000494:pharmacology*; D051381:Rats; D017981:Receptors, Neurotransmitter / Q000187:drug effects; D013331:Strychnine / Q000494:pharmacology; D005680:gamma-Aminobutyric Acid / Q000378:metabolism / Q000494:pharmacology*
D000613:Aminobutyrates; D001463:Barbiturates; D018756:GABA Antagonists; D007546:Isoquinolines; D017981:Receptors, Neurotransmitter; D005680:gamma-Aminobutyric Acid; D013331:Strychnine; D010424:Pentobarbital; D005998:Glycine; D001640:Bicuculline